Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2026年2月24-26日
日本, 東京, Grand Nikko Tokyo Daiba

主要会议第3天

主要会议第3天
Plenary Session
全体会议
7:45am - 8:10am25 分
Plenary Sessions
全体会议
Registration and Coffee
报到与咖啡时光
    8:10am - 8:15am5 分
    Plenary Sessions
    全体会议
    Chairperson’s Remarks: Plenary Day 3
    议长致辞：全体会议第3天
      8:15am - 8:45am30 分
      Plenary Sessions
      全体会议
      Surface Avidity Optimization Drives Potent CAR-T Generation with Targeted LNPs
      优化表面亲和性，透过靶向 LNP 推动有效的 CAR-T 生成
      • Hiroshi Yamada, PhD - Head of Drug Delivery Research and Development, Nitto Denko Corporation
      8:45am - 9:15am30 分
      Plenary Sessions
      全体会议
      FORCE Platform Enables TfR1-mediated Delivery of Therapeutics for Rare Neuromuscular Diseases
      FORCE平台实现了针对罕见神经肌肉疾病的TfR1介导的药物递送
      • Stefano Zanotti, PhD - VP, Head of Neuromuscular Research, Dyne Therapeutics
      9:15am - 9:45am30 分
      Plenary Sessions
      全体会议
      A Deep Dive into Detritylation Making it Safer and Sustainable
      深入研究去三苯乙醯化，使其更安全、更永续
      • Yogesh Sanghvi, PhD - President, Rasayan Inc.
      9:45am - 10:15am30 分
      Plenary Sessions
      全体会议
      Regulatory CMC Challenges and Strategies for Oligonucleotide and Peptide Programs under Accelerated Review
      迅速审查对象──寡核苷酸和胜肽计划上的法规上CMC课题及策略
      • David Lin, PhD - President and Principal Consultant, TS Pharma Experts LLC
      10:15am - 10:55am40 分
      Plenary Sessions
      全体会议
      Networking Refreshment Break with Poster and Exhibit Viewing
      社交茶歇 （包含参观海报/展览）
        Concurrent Conference Tracks
        同时举行的会议分会
        10:55am - 11:00am5 分
        Oligonucleotide Track
        寡核苷酸分会
        Chairperson’s Remarks: Track 1
        议长致辞：分会1
          10:55am - 11:00am5 分
          Peptide Track
          胜肽分会
          Chairperson’s Remarks: Track 2
          议长致辞：分会2
          • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
          11:00am - 11:30am30 分
          Oligonucleotide Track
          寡核苷酸分会
          Extending Oligonucleotide Delivery and Gene Knockdown to Specific Cell Types in Kidney
          扩展肾脏上特定细胞型的寡核苷酸递送与基因敲低至肾脏中特定细胞类型
          • Alfica Sehgal, PhD - Chief Scientific Officer, Judo Bio
          11:00am - 11:30am30 分
          Peptide Track
          胜肽分会
          PolyPeptide Key Technology Enablers to Speed Up IND and Early Clinical Trials
          加速IND和早期临床试验的PolyPeptide主要技术成功因素
          • Fabien Rousset, PhD - Global Director of Innovation, Polypeptide Group
          11:30am - 12:00pm30 分
          Oligonucleotide Track
          寡核苷酸分会
          Expanding RNA Editing Applications to CNS Disorders Through AIMer Chemistry Design
          透过 AIMer 化学设计将 RNA 编辑应用扩展到中枢神经系统疾病
          • Chikdu Shivalila, PhD - Senior Scientist, Biology, Wave Life Sciences
          11:30am - 12:00pm30 分
          Peptide Track
          胜肽分会
          Greener, Smarter Peptide Manufacturing: Advancing Sustainability and Quality
          更环保、更智慧的胜肽制造：提升永续性和品质
          • Anubrato Aich - Senior Project Manager, AmbioPharm
          12:00pm - 12:30pm30 分
          Oligonucleotide Track
          寡核苷酸分会
          Leveraging IGF1R Receptor for Antisense Delivery
          利用 IGF1R 受体进行反义递送
          • Hien Zhao, PhD - Vice President, Neuroscience Research, Ionis Pharmaceuticals
          12:00pm - 12:30pm30 分
          Peptide Track
          胜肽分会
          Driving Further Evolution in Peptide API Downstream Processing
          推动胜肽 API 下游加工的进一步进化
          • Yuta Hiroyama - Senior Scientist, Process Chemistry Group, R&D Department, PeptiStar
          12:30pm - 1:40pm70 分
          Oligonucleotide Track
          寡核苷酸分会
          Networking Luncheon with Poster and Exhibit Viewing
          交流午餐会 （包含参观海报/展览）
            12:30pm - 1:40pm70 分
            Peptide Track
            胜肽分会
            Networking Luncheon with Poster and Exhibit Viewing
            交流午餐会 （包含参观海报/展览）
              1:40pm - 1:45pm5 分
              Oligonucleotide Track
              寡核苷酸分会
              Chairperson's Remarks: Track 1
              议长致辞：分会1
                1:40pm - 1:45pm5 分
                Peptide Track
                胜肽分会
                Chairperson’s Remarks: Track 2
                议长致辞：分会2
                • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
                1:45pm - 2:15pm30 分
                Oligonucleotide Track
                寡核苷酸分会
                Precision-Engineered SNPD-siRNAs for Allele-Specific Silencing of Disease-Causing Mutations
                用于致病突变的等位基因特异性沉默的精密工程 SNPD-siRNA
                • Kumiko Ui-Tei, PhD - CTO, ANRis Therapeutics and Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center, Institute of Science Tokyo
                1:45pm - 2:15pm30 分
                Peptide Track
                胜肽分会
                Advancing Mid-sized Drug Discovery through Scalable Unnatural Amino Acid Technologies
                透过可扩展的非天然胺基酸技术推进中型药物研发
                • Manabu Wadamoto, PhD - Chief Scientist, Chugai Pharmaceutical Co., Ltd.
                2:15pm - 2:45pm30 分
                Oligonucleotide Track
                寡核苷酸分会
                Advancing RNA Therapeutics: Preclinical Translation of Antibody Oligonucleotide Conjugates (AOC)
                RNA医学的进步：AOC的临床前翻译
                • Husam Younis, PhD - Senior Vice President, Development Science, Avidity Biosciences
                2:15pm - 2:45pm30 分
                Peptide Track
                胜肽分会
                Antibody-inducing Peptide Using Universal Epitopes: Concept and Clinical Update
                使用通用表位的抗体诱导肽：概念和临床更新
                • Hideki Tomioka, PhD - Director of the Board and CSO, FunPep Co., Ltd.
                2:45pm - 3:15pm30 分
                Oligonucleotide Track
                寡核苷酸分会
                LC-HRMS Bioanalytical Strategies for Characterizing and Quantifying Antibody-Oligonucleotide Conjugate (AOC) Therapeutics
                用于 AOC 药物表征和定量化的 LC-HRMS 生物分析策略
                • Xin Zhang, PhD - Principal Scientist, Denali Therapeutics
                2:45pm - 3:15pm30 分
                Peptide Track
                胜肽分会
                A Bioproduction Platform to Generate Functionalized Disulfide-constrained Peptide Analogues
                用于生成功能化二硫键约束肽类似物的生物生产平台
                • Sunhee Hwang, PhD - Scientist 4, Genentech
                3:15pm - 3:45pm30 分
                Oligonucleotide Track
                寡核苷酸分会
                Networking Refreshment Break with Poster and Exhibit Viewing
                社交茶歇 （包含参观海报/展览）
                  3:15pm - 3:45pm30 分
                  Peptide Track
                  胜肽分会
                  Networking Refreshment Break with Poster and Exhibit Viewing
                  社交茶歇 （包含参观海报/展览）
                    3:45pm - 4:15pm30 分
                    Oligonucleotide Track
                    寡核苷酸分会
                    The Analytical Method Development Challenges of a Peptide PMO Conjugate, VP-001 for the Treatment of Retinitis Pigmentosa RP-11
                    开发用于治疗色素性视网膜炎RP-11的VP-001（肽-PMO偶联物）分析方法的课题
                    • Mark Anastasas - Group Lead Chemistry-QC, PYC Therapeutics
                    3:45pm - 4:15pm30 分
                    Peptide Track
                    胜肽分会
                    Late Breaking Presentation
                    最新简报
                      4:15pm - 4:45pm30 分
                      Oligonucleotide Track
                      寡核苷酸分会
                      Optimizing Oligo Protein Conjugates with Chemistry-Driven Solutions for Enhanced Properties and Scale-Up
                      透过化学驱动的解决方案优化寡核苷酸蛋白偶联物，以提升性能并实现规模化生产
                      • Naresh Jain, PhD - CEO, NJ Bio
                      4:15pm - 4:45pm30 分
                      Peptide Track
                      胜肽分会
                      Late Breaking Presentation
                      最新简报
                        4:45pm - 5:15pm30 分
                        Oligonucleotide Track
                        寡核苷酸分会
                        Precise Engineering and Structural Elucidation of Aptamer-Drug Conjugates (ApDC) for Implantable Triple-Negative Breast Cancer (TNBC) Therapy
                        阐明三阴性乳癌 （TNBC）植入治疗上的ApDC精密工学与构造
                        • Jung Hwan Lee, PhD - CEO, Interoligo Corp.
                        4:45pm - 5:15pm30 分
                        Peptide Track
                        胜肽分会
                        Late Breaking Presentation
                        最新简报
                          5:15pm - 5:20pm5 分
                          Oligonucleotide Track
                          寡核苷酸分会
                          Close of Conference
                          会议闭幕
                            5:15pm - 5:20pm5 分
                            Peptide Track
                            胜肽分会
                            Close of Conference
                            会议闭幕

                              * 活动内容有可能不事先告知作更动及调整。

                              主要会议第2天